期刊文献+

自发性静脉血栓栓塞症的实验室独立危险因素的新发现

The New Findings of the Independent Risk Factors of Laboratory Indexes of the Idiopathic Venous Thromboembolism
暂未订购
导出
摘要 发现与自发性静脉血栓栓塞症发生相关的实验室检测指标,对连续收集的48例既往无血栓病史的、首发的自发性静脉血栓栓塞症住院患者(以及48例未发生静脉血栓性疾病的住院患者做为对照组)进行实验室相关指标。包括:纤维蛋白原含量、白细胞计数、血小板计数和ABO血型的检测,并对这些实验室相关指标与自发性静脉血栓栓塞症的相关性分别进行单因素和多因素的统计学分析。结果单因素统计分析发现,纤维蛋白原含量和白细胞计数在血栓组与对照组间存在显著的差异(P<0.05),而血小板计数和ABO血型在两组间差异无统计学意义(P>0.05)。对纤维蛋白原含量和白细胞计数与自发性静脉血栓栓塞症之间的相关性进行Logistic回归分析发现,纤维蛋白原含量和白细胞计数均为自发性静脉血栓栓塞症发生的独立危险因素,其OR值分别为纤维蛋白原含量2.17(95%CI:1.306~3.608,p值=0.002 8)和白细胞计数1.36(95%CI:1.074~1.719,p值=0.010 6)。结论纤维蛋白原含量和白细胞计数是自发性静脉血栓栓塞症的独立危险因素,通过与其他临床相关因素结合,可能有助于自发性静脉血栓栓塞症的预警和早期诊断。 To find the laboratory-related indexes of idiopathic venous thromboembolism.We laboratory-related indexes(Fibriogen,White Blood Cell,Platelet,ABO blood type) for hospitalized patients of no history of thrombosis and the first idiopathic venous thromboembolism is examined.Univariate and multivariate statistical analysis of the correlation between these laboratory-related indexes and the idiopathic venous thromboembolism.It is resulted that through the univariate analysis,Fbg and WBC were higher in"thrombosis group"than in "the control group"(P0.05),PLT and ABO blood type were not difference between "thrombosis group"and"the control group"(P0.05).Through the Logistic regression model analysis,Fbg and WBC were the independent risk factors of the idiopathic venous thromboembolism(P0.05),the odds ratio were 2.17,1.36.The overall partial regression coefficient of 95% confidence interval were 1.306~3.608,1.074~1.719.It is conclused that laboratory-related indexes(Fbg,WBC) are the independent risk factors of the idiopathic venous thromboembolism.By combination with the other clinically relevant factors,it may contribute to the early warning and early diagnosis of the idiopathic venous thromboembolism.
出处 《科学技术与工程》 北大核心 2012年第13期3078-3083,共6页 Science Technology and Engineering
基金 国家自然科学基金面上项目(30971259)资助
关键词 自发性静脉血栓栓塞症 纤维蛋白原 白细胞计数 危险因素 idiopathic venous thromboembolism fibrinogen white blood cell count risk factor
  • 相关文献

参考文献25

  • 1White R H. The epidemiology of venous thromboembolism. Circulation, 2003;107:14-18.
  • 2Mosor K M, Fedullo P F, Littejohn J K, et al. Frequent asymptomat- ic pulmonary in patients with deep venous thrombosis. JAMA, 1994; 271 (3) :223-225.
  • 3Merjer P, Kluft C. The harmonization of quantitative test results of dif- ferent D-dimer methods. Semin Vasc Med,2005 ;5 (4) :321-327.
  • 4Geersing G J, Janssen K, Oudega R, et al. Excuding venous thrombo- embolism using point of care D-dimer tests in outpatients : a diagnostic meta-analysis. BMJ ,2009 ;339:2990-2999.
  • 5包承鑫.血栓前状态的实验诊断[J].诊断学理论与实践,2008,7(5):470-472. 被引量:5
  • 6Tsai A W, Cushman M, Rosamond W D, et al. Inflammation markes, and venous thromboembolism: the longitudinal investigation of thmm- boembolism etio I ogy(LITE). Am J Med, 2002 ; 113 ( 8 ) :636-642.
  • 7Van Hylckama Vlieg A, Rosendaal F R. High levels of fibrinogen are associated with the risk of deeop vein thrombosis mainly in the elder- ly. J Thromb Haemost, 2003 ;1 (12) :2677-2678.
  • 8De Willige S, De Visser M C, Houwing-Duistermaat J J, et al. Ge- netic variation in the fibrinogen gamma gene increases the risk for deep venous thrmnbosis by reducing plasma fibrinogen r' levels. Blood, 2005 ; 106(13) : 4176-4183.
  • 9Luxembourg B, Schmitt J, Humpich M, et al. Cardiovascular risk factors in idiopathic compared to risk associated venous thromboembo- lism:A focus on fibrinogen, factor Ⅷ, and high-sensitivity C-reactive protein(hs-CRP) . Thromb Haemost,2009 ; 102(4) :668-675.
  • 10李积凤,王辰,王军.纤维蛋白原编码区SNP与血栓性疾病的关系及机制[J].首都医科大学学报,2010,31(5):558-562. 被引量:8

二级参考文献44

  • 1[2]Reitsma PH,Rosendaal FR.Past and future of genetic research in thrombosis[J].J Thromb Haemost,2007,5(Suppl 1):264-269.
  • 2[4]Lindemann S,Kramer B,Seizer P,et al.Platelets,inflammation and atherosclerosis[J].J Thromb Haemost,2007,5(Suppl 1):203-211.
  • 3[5]Cushman M.Epidemiology and risk factors for venous thrombosis[J].Semin Hematol,2007,44(2):62-69.
  • 4[6]Nossent AY,Eikenboom JC,Bertina RM.Plasma coagulation factor levels in venous thrombosis[J].Semin Hematol,2007,44(2):77-84.
  • 5[7]Heit JA.Thrombophilia:common questions on laboratory assessment and management[J].Hematology Am Soc Hematol Educ Program,2007:127-135.
  • 6[9]Lochhead P,Miedzybrodzka Z.The essential role of genetic counseling in inherited thrombophilia[J].Semin Hematol,2007,44(2):126-129.
  • 7[10]Cohn DM,Roshani S,Middeldorp S.Thrombophilia and venous thromboembolism:implications for testing[J].Semin Thromb Hemost,2007,33(6):573-581.
  • 8[11]Bezemer ID,Rosendatd FR.Predictive genetic variants for venous thrombosis:what's new?[J].Semin Hematol,2007,44(2):85-92.
  • 9[12]Bauer KA.Management of thrombophilia[J].J Thromb Haemost,2003,1(7):1429-1434.
  • 10Muszbek L,Adany R,Mikkola H.Novel aspects of blood coagulation factor XIII.I.Structure,distribution,activation,and function[J].Criti Rev Clin Lab Sci,1996,33:357-421.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部